VK
Virender Kumar Kaul
About Virender Kumar Kaul
Data last updated:
Virender Kumar Kaul is a Director at Modgal Pharmaceuticals Pvt Ltd (since 1991) and Director at Unimarck Bioethicals Private Limited (since 2019). The companies operate in Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹1.27 Cr; the largest is Modgal Pharmaceuticals Pvt Ltd at ₹66.6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Mar 1991 | 1983 | ₹66.6 Lakh (FY 2025) | Active | |
| Director | 20 Dec 2019 | 2005 | ₹60.5 Lakh (FY 2024) | Active |
Board colleagues of Virender Kumar Kaul
| Name | DIN | Company | Designation |
|---|---|---|---|
| Viveak Kaul | 02368844 | Modgal Pharmaceuticals Pvt Ltd | Director |
| Santosh Kaul | 03192490 | Unimarck Bioethicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Virender Kumar Kaul
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Virender Kumar Kaul
Virender Kumar Kaul currently holds 2 directorships: Modgal Pharmaceuticals Pvt Ltd (Director, since 23 Mar 1991, revenue ₹66.6 Lakh (FY 2025)); Unimarck Bioethicals Private Limited (Director, since 20 Dec 2019, revenue ₹60.5 Lakh (FY 2024)).
Virender Kumar Kaul was first appointed on 23 Mar 1991 as Director at Modgal Pharmaceuticals Pvt Ltd. The most recent appointment on record is 20 Dec 2019 at Unimarck Bioethicals Private Limited.
The 2 current companies of Virender Kumar Kaul that report revenue have a combined latest revenue of ₹1.27 Cr: Modgal Pharmaceuticals Pvt Ltd ₹66.6 Lakh (FY 2025); Unimarck Bioethicals Private Limited ₹60.5 Lakh (FY 2024).
The current boards of Virender Kumar Kaul's companies include Viveak Kaul (Modgal Pharmaceuticals Pvt Ltd), Santosh Kaul (Unimarck Bioethicals Private Limited).